## Abstract The __6055G>A__ mutation in the __leucine‐rich repeat kinase 2__ (__LRRK2__) gene results in a G2019S substitution in the mixed‐lineage kinase domain of Lrrk2, causing autosomal dominant Parkinson's disease (PD). We hypothesized the mutation alters cellular mitogen‐activated protein kin
Kin-cohort analysis of LRRK2-G2019S penetrance in Parkinson's disease
✍ Scribed by Stefano Goldwurm; Sara Tunesi; Silvana Tesei; Michela Zini; Francesca Sironi; Paola Primignani; Corrado Magnani; Gianni Pezzoli
- Book ID
- 102945937
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 1023 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Posterior cortical atrophy (PCA) represents a degenerative disorder characterized by the development of higherorder visual deficit. 1 PCA may result from heterogeneous pathologies that make up tauopathies. An increasing number of mutations in the tau gene (microtubule-associated protein tau [MAPT]) causes a wide spectrum of clinical presentations known as frontotemporal dementia with parkinsonism linked to chromosome-17 (FTDP-17). 2 Symptomatology usually involves executive dysfunction and altered personality and behavior, with patients displaying parkinsonian features.
We describe the case of a woman with PCA who further developed asymmetric motor signs. A mutation in the MAPT gene was detected, and a diagnosis of FTDP-17 was formulated. To our knowledge, this is the very first report of a patient suffering from FTDP-17 diagnosed with posterior cortical atrophy.
Case Report
A 55-year-old woman started suffering in 2006 from altered perception of human faces. Initially the visual distortion was fluctuating; over the following year it became constant, and she could not recognize her husband and children by their faces anymore. She further developed visuospatial deficits, with difficulty in localizing stimuli, judging distances, or orienting herself in familiar surroundings. A first neurological examination revealed visual agnosia. She had no visual hallucinations or personality changes. Biochemical investigations and CSF analysis were normal. Her mother suffered from dementia that started when she was 80. Genetic tests for Alzheimer's disease genes (betaPP, PS1, PS2) were performed, revealing normal alleles.
As the disease progressed, she developed difficulties manipulating objects with her left hand. On further neurological examination, she showed marked ocular apraxia, and she appeared to be cortically blind. Motor signs appeared and were confined to her left arm, with plastic rigidity, bradykinesia, and postural tremor; dopaminergic treatment was not tolerated.
Brain magnetic resonance imaging (MRI) showed slight signal alteration in parieto-occipital white matter bilaterally without significant atrophy; an 18F-FDG PET brain study demonstrated decreased metabolism in the posterior parietal and occipital regions, compatible with PCA. To investigate
📜 SIMILAR VOLUMES
## Abstract Mutations in the leucine‐rich repeat kinase 2 (__LRRK2__) gene have been shown to cause autosomal dominant and sporadic Parkinson's disease (PD). We report here the frequency of a common heterozygous mutation, 2877510G>A, which produces a glycine‐to‐serine amino acid substitution at cod
## Abstract The frequency and penetrance of the LRRK2 G2019S mutation varies considerably in different Parkinson disease (PD) populations. This information is essential both for clinical purposes and genetic counseling. The objective of this study was to estimate the prevalence and penetrance of th